Although laboratorial findings reported previously strongly suggested ADAM12, ADAM19, ADAM23, and ADAMTS6 were potential participants in bone metabolism, our two-sample MR estimates had great robustness to support no MR association between levels of these metallopeptidases and osteoporosis based on the results of various MR methods and sensitivity analyses. This evidence concerns the gene ADAM12 and osteoporosis.